Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENERGISED: Gut Microbiota and Immune Cell Energy Metabolism in Health and IBD
NCT07300553Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Impact of gut microbiota on peripheral immune cells energy metabolism at 7 days. Started Jan 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07300553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300553.